Key points are not available for this paper at this time.
This study delves into the therapeutic potential of Syzygium cumini, a medicinal plant known for its rich bioactive compounds such as quercetin, myricetin, myrcene, and β-sitosterol. By using a network pharmacology approach, we aimed to uncover the mechanisms behind its pharmacological effects, especially concerning breast cancer management and its associated complications. Firstly, we conducted an extensive analysis of the bioactive compounds in S. cumini, identifying numerous molecules with potential therapeutic benefits. These compounds, recognized for their varied biological activities, provided a foundation for understanding the plant’s medicinal properties. Next, using network pharmacology techniques, we explored the complex interactions between these bioactive compounds and their potential targets within the human body. By mapping out these targets and disease-related genes, we built a network that illuminated the intricate mechanisms through which S. cumini exerts its effects. Particularly intriguing were the high-affinity interactions found, such as those between prostaglandinendoperoxide synthase 2 and Cytochrome P450 Family 19 Subfamily A Member 1. These interactions are promising for targeted therapeutic interventions and warrant further investigation to fully understand their roles in disease modulation. Additionally, pathway analysis highlighted several key biological processes and signaling pathways involved in breast cancer pathogenesis. Metabolic pathways, estrogen signaling, and proteoglycans in cancer emerged as crucial pathways influenced by the bioactive compounds in S. cumini. Understanding how these pathways are modulated provides valuable insights into the plant’s potential effectiveness in breast cancer management. In summary, our study offers a deeper insight into the pharmacological properties of S. cumini and its potential application in breast cancer therapy. By elucidating the molecular mechanisms behind its therapeutic effects, we pave the way for further exploration and clinical development of this herbal remedy for breast cancer and its related complications.
Bethi et al. (Tue,) studied this question.